Marc A. Kerenyi

3.3k total citations
27 papers, 2.4k citations indexed

About

Marc A. Kerenyi is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Marc A. Kerenyi has authored 27 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 13 papers in Immunology and 12 papers in Oncology. Recurrent topics in Marc A. Kerenyi's work include Cytokine Signaling Pathways and Interactions (10 papers), Epigenetics and DNA Methylation (9 papers) and T-cell and B-cell Immunology (4 papers). Marc A. Kerenyi is often cited by papers focused on Cytokine Signaling Pathways and Interactions (10 papers), Epigenetics and DNA Methylation (9 papers) and T-cell and B-cell Immunology (4 papers). Marc A. Kerenyi collaborates with scholars based in United States, Austria and France. Marc A. Kerenyi's co-authors include Stuart H. Orkin, Richard Moriggl, Guoji Guo, Lothar Hennighausen, Tobias Neff, Woojin Kim, Hartmut Beug, Boris Kovačic, Loren D. Walensky and Gregory H. Bird and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Marc A. Kerenyi

26 papers receiving 2.4k citations

Peers

Countries citing papers authored by Marc A. Kerenyi

Since Specialization

Citations

This map shows the geographic impact of Marc A. Kerenyi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc A. Kerenyi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc A. Kerenyi more than expected).

Fields of papers citing papers by Marc A. Kerenyi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc A. Kerenyi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc A. Kerenyi. The network helps show where Marc A. Kerenyi may publish in the future.

Co-authorship network of co-authors of Marc A. Kerenyi

This figure shows the co-authorship network connecting the top 25 collaborators of Marc A. Kerenyi. A scholar is included among the top collaborators of Marc A. Kerenyi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc A. Kerenyi. Marc A. Kerenyi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	O-GlcNAcylation of STAT5 controls tyrosine phosphorylation and oncogenic transcription in STAT5-dependent malignancies 2017 ·Leukemia ·(unknown), Marc A. Kerenyi, Marlene Hager, Tobias Wagner, Bettina Wingelhofer, Hà Phạm, (unknown), Xiaonan Han, Peter Valent, Fabrice Gouilleux, Veronika Sexl, Oliver H. Krämer, Bernd Groner, Richard Moriggl	49
2	Abstract 4630: Development of selective and potent CDK8 inhibitors that increase NK cell activity, which translates in tumor surveillance 2017 ·Cancer Research ·Marco H. Hofmann, Harald Engelhardt, Sebastian Carotta, Heribert Arnhof, Dirk Scharn, Marc A. Kerenyi, (unknown), (unknown), (unknown), (unknown), Michael P. Sanderson, (unknown), Renate Schnitzer, Mark Pearson, Darryl B. McConnell, Norbert Kraut, Jürgen Moll	1
3	The histone demethylase UTX regulates the lineage-specific epigenetic program of invariant natural killer T cells 2016 ·Nature Immunology ·Semir Beyaz, Ji Hyung Kim, Luca Pinello, Michael E. Xifaras, Yu Hu, Jialiang Huang, Marc A. Kerenyi, Partha Pratim Das, R. Anthony Barnitz, Aurélie Hérault, (unknown), W. Nicholas Haining, Ömer Yılmaz, Emmanuelle Passegué, Guo‐Cheng Yuan, Stuart H. Orkin, Florian Winau	42
4	Scl binds to primed enhancers in mesoderm to regulate hematopoietic and cardiac fate divergence 2015 ·The EMBO Journal ·Tõnis Org, Dan Duan, Roberto Ferrari, Amélie Montel‐Hagen, Ben Van Handel, Marc A. Kerenyi, Rajkumar Sasidharan, Liudmilla Rubbi, Yuko Fujiwara, Matteo Pellegrini, Stuart H. Orkin, Siavash K. Kurdistani, Hanna Mikkola	59
5	LSD1 is essential for oocyte meiotic progression by regulating CDC25B expression in mice 2015 ·Nature Communications ·Jeesun Kim, Anup K. Singh, Yoko Takata, Kevin Lin, Jianjun Shen, Yue Lu, Marc A. Kerenyi, Stuart H. Orkin, Taiping Chen	42
6	LT-HSC Methylcellulose Assay 2014 ·BIO-PROTOCOL ·Marc A. Kerenyi	7
7	Mapping Cellular Hierarchy by Single-Cell Analysis of the Cell Surface Repertoire 2013 ·Cell stem cell ·Guoji Guo, Sidinh Luc, Eugenio Marco, (unknown), Cong Peng, Marc A. Kerenyi, Semir Beyaz, Woojin Kim, Jian Xu, Partha Pratim Das, Tobias Neff, Keyong Zou, Guo‐Cheng Yuan, Stuart H. Orkin	175
8	Targeted disruption of the EZH2–EED complex inhibits EZH2-dependent cancer 2013 ·Nature Chemical Biology ·Woojin Kim, Gregory H. Bird, Tobias Neff, Guoji Guo, Marc A. Kerenyi, Loren D. Walensky, Stuart H. Orkin	266
9	Corepressor-dependent silencing of fetal hemoglobin expression by BCL11A 2013 ·Proceedings of the National Academy of Sciences ·Jian Xu, Daniel E. Bauer, Marc A. Kerenyi, Thuy D. Vo, Serena Hou, (unknown), Huilan Yao, Jennifer J. Trowbridge, Gail Mandel, Stuart H. Orkin	176
10	Abstract B254: Targeted disruption of the EZH2-EED complex inhibits EZH2-dependent cancer. 2013 ·Molecular Cancer Therapeutics ·Woojin Kim, Gregory H. Bird, Tobias Neff, Guoji Guo, Marc A. Kerenyi, Loren D. Walensky, Stuart H. Orkin	0
11	Histone demethylase Lsd1 represses hematopoietic stem and progenitor cell signatures during blood cell maturation 2013 ·eLife ·Marc A. Kerenyi, Zhen Shao, (unknown), Guoji Guo, Sidinh Luc, (unknown), Yuko Fujiwara, Cong Peng, Minh Nguyen, Stuart H. Orkin	194
12	Networking erythropoiesis 2010 ·The Journal of Experimental Medicine ·Marc A. Kerenyi, Stuart H. Orkin	65
13	Expression of Activated STAT5 in Neoplastic Mast Cells in Systemic Mastocytosis 2009 ·American Journal Of Pathology ·Christian Baumgärtner, Sabine Cerny‐Reiterer, Karoline Sonneck, Matthias Mayerhofer, Karoline V. Gleixner, Richard R. Fritz, Marc A. Kerenyi, Cédric Boudot, Fabrice Gouilleux, Jan‐Wilhelm Kornfeld, Christian Sillaber, Richard Moriggl, Peter Valent	60
14	Loss of nucleoplasmic LAP2α–lamin A complexes causes erythroid and epidermal progenitor hyperproliferation 2008 ·Nature Cell Biology ·Nana Naetar, Barbara Korbei, С. В. Козлов, Marc A. Kerenyi, (unknown), (unknown), Ivana Gotić, Peter Fuchs, Tatiana V. Cohen, Reginald E. Bittner, Colin L. Stewart, Roland Foisner	132
15	Stat5 activation enables erythropoiesis in the absence of EpoR and Jak2 2008 ·Blood ·Florian Grebien, Marc A. Kerenyi, Boris Kovačic, Thomas Kolbe, Verena Becker, Helmut Dolznig, Klaus Pfeffer, Ursula Klingmüller, Mathias Müller, Hartmut Beug, Ernst W. Müllner, Richard Moriggl	81
16	Nonredundant roles for Stat5a/b in directly regulating Foxp3 2007 ·Blood ·Zhengju Yao, Yuka Kanno, Marc A. Kerenyi, Geoffrey L. Stephens, Lydia Durant, Wendy T. Watford, Arian Laurence, Gertraud W. Robinson, Ethan M. Shevach, Richard Moriggl, Lothar Hennighausen, Changyou Wu, John J. O’Shea	471
17	Clarifying the role of Stat5 in lymphoid development and Abelson-induced transformation 2006 ·Blood ·Andrea Hoelbl‐Kovacic, Boris Kovačic, Marc A. Kerenyi, Olivia Simma, Wolfgang Warsch, Yongzhi Cui, Hartmut Beug, Lothar Hennighausen, Richard Moriggl, Veronika Sexl	168
18	Regulation of matrilysin expression in endothelium by fibroblast growth factor-2 2006 ·Biochemical and Biophysical Research Communications ·Wolfgang Holnthoner, Marc A. Kerenyi, Marion Gröger, Franz Kratochvill, Peter Petzelbauer	18
19	Erythroid progenitor renewal versus differentiation: genetic evidence for cell autonomous, essential functions of EpoR, Stat5 and the GR 2005 ·Oncogene ·Helmut Dolznig, Florian Grebien, Eva Maria Deiner, (unknown), Andrea Kolbus, Bianca Habermann, Marc A. Kerenyi, Matthias Kieslinger, Richard Moriggl, Hartmut Beug, Elisabeth Müllner	44
20	Detection of Activated STAT5 in Neoplastic Mast Cells in Patients with Systemic Mastocytosis: Role of c-kit D816V. 2005 ·Blood ·Karoline Sonneck, Matthias Mayerhofer, Karoline V. Gleixner, Marc A. Kerenyi, Maria‐Theresa Krauth, Richard R. Fritz, Christian Sillaber, Richard Moriggl, Peter Valent	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact